Blood Vessel-Derived Acellular Matrix for Vascular Graft Application
Figure 2
Cultures of skin microvascular ECs on tissue culture treated plates (a, b) and AMs (c, d). (a) Phase-contrast microscopy (magnification ×100). (b) Immunofluorescence carried out using anti-von Willebrand factor antibody (magnification ×400). (c), (d) SEM micrographs of ECs/AM cultures at 72 h from seeding.
